Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 2
1958 1
1959 1
1960 1
1961 1
1962 1
1963 4
1964 7
1965 6
1966 5
1967 7
1968 7
1969 6
1970 8
1971 4
1972 10
1973 10
1974 9
1975 9
1976 6
1977 10
1978 9
1979 16
1980 10
1981 8
1982 14
1983 16
1984 21
1985 30
1986 26
1987 42
1988 50
1989 45
1990 46
1991 44
1992 54
1993 43
1994 53
1995 51
1996 48
1997 40
1998 49
1999 56
2000 34
2001 45
2002 53
2003 43
2004 33
2005 43
2006 33
2007 37
2008 41
2009 38
2010 46
2011 65
2012 56
2013 59
2014 64
2015 78
2016 69
2017 91
2018 117
2019 93
2020 121
2021 69
Text availability
Article attribute
Article type
Publication date

Search Results

2,073 results
Results by year
Filters applied: . Clear all
Page 1
Eteplirsen in the treatment of Duchenne muscular dystrophy.
Lim KR, Maruyama R, Yokota T. Lim KR, et al. Among authors: yokota t. Drug Des Devel Ther. 2017 Feb 28;11:533-545. doi: 10.2147/DDDT.S97635. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28280301 Free PMC article. Review.
Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury.
Yokota T, McCourt J, Ma F, Ren S, Li S, Kim TH, Kurmangaliyev YZ, Nasiri R, Ahadian S, Nguyen T, Tan XHM, Zhou Y, Wu R, Rodriguez A, Cohn W, Wang Y, Whitelegge J, Ryazantsev S, Khademhosseini A, Teitell MA, Chiou PY, Birk DE, Rowat AC, Crosbie RH, Pellegrini M, Seldin M, Lusis AJ, Deb A. Yokota T, et al. Cell. 2020 Aug 6;182(3):545-562.e23. doi: 10.1016/j.cell.2020.06.030. Epub 2020 Jul 3. Cell. 2020. PMID: 32621799
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Kawanami D, Matoba K, Takeda Y, Nagai Y, Akamine T, Yokota T, Sango K, Utsunomiya K. Kawanami D, et al. Among authors: yokota t. Int J Mol Sci. 2017 May 18;18(5):1083. doi: 10.3390/ijms18051083. Int J Mol Sci. 2017. PMID: 28524098 Free PMC article. Review.
Nusinersen in the Treatment of Spinal Muscular Atrophy.
Goodkey K, Aslesh T, Maruyama R, Yokota T. Goodkey K, et al. Among authors: yokota t. Methods Mol Biol. 2018;1828:69-76. doi: 10.1007/978-1-4939-8651-4_4. Methods Mol Biol. 2018. PMID: 30171535 Review.
Immunotherapy for squamous cell carcinoma of the head and neck.
Yokota T, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ogawa T, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Yokota T, et al. Jpn J Clin Oncol. 2020 Sep 28;50(10):1089-1096. doi: 10.1093/jjco/hyaa139. Jpn J Clin Oncol. 2020. PMID: 32776100 Review.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: yokota t. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
2,073 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page